244 related articles for article (PubMed ID: 8494367)
1. Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice.
Khardori N; Nguyen H; Stephens LC; Kalvakuntla L; Rosenbaum B; Bodey GP
Antimicrob Agents Chemother; 1993 Apr; 37(4):729-36. PubMed ID: 8494367
[TBL] [Abstract][Full Text] [Related]
2. Synergy between cilofungin and amphotericin B in a murine model of candidiasis.
Hanson LH; Perlman AM; Clemons KV; Stevens DA
Antimicrob Agents Chemother; 1991 Jul; 35(7):1334-7. PubMed ID: 1929290
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis.
Morrison CJ; Stevens DA
Antimicrob Agents Chemother; 1990 May; 34(5):746-50. PubMed ID: 2193617
[TBL] [Abstract][Full Text] [Related]
4. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
Fong IW; Bannatyne RM; Cheng PC
Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
[TBL] [Abstract][Full Text] [Related]
5. Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis.
Walsh TJ; Lee JW; Kelly P; Bacher J; Lecciones J; Thomas V; Lyman C; Coleman D; Gordee R; Pizzo PA
Antimicrob Agents Chemother; 1991 Jul; 35(7):1321-8. PubMed ID: 1929288
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.
Bannatyne RM; Cheng PC; Fong IW
Infection; 1992; 20(3):168-70. PubMed ID: 1644494
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits.
Rouse MS; Tallan BM; Steckelberg JM; Henry NK; Wilson WR
Antimicrob Agents Chemother; 1992 Jan; 36(1):56-8. PubMed ID: 1590700
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbits.
Padula A; Chambers HF
Antimicrob Agents Chemother; 1989 Oct; 33(10):1822-3. PubMed ID: 2686548
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cilofungin and amphotericin B for therapy of murine candidiasis.
Smith KR; Lank KM; Cobbs CG; Cloud GA; Dismukes WE
Antimicrob Agents Chemother; 1990 Aug; 34(8):1619-21. PubMed ID: 2221875
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a murine model of hepatic candidiasis.
Cole GT; Lynn KT; Seshan KR
J Clin Microbiol; 1990 Aug; 28(8):1828-41. PubMed ID: 2394804
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
Bartizal K; Abruzzo G; Trainor C; Krupa D; Nollstadt K; Schmatz D; Schwartz R; Hammond M; Balkovec J; Vanmiddlesworth F
Antimicrob Agents Chemother; 1992 Aug; 36(8):1648-57. PubMed ID: 1416847
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis.
Ikeda F; Wakai Y; Matsumoto S; Maki K; Watabe E; Tawara S; Goto T; Watanabe Y; Matsumoto F; Kuwahara S
Antimicrob Agents Chemother; 2000 Mar; 44(3):614-8. PubMed ID: 10681327
[TBL] [Abstract][Full Text] [Related]
13. Treatment of murine invasive candidiasis with amphotericin B and cilofungin: evidence for enhanced activity with combination therapy.
Sugar AM; Goldani LZ; Picard M
Antimicrob Agents Chemother; 1991 Oct; 35(10):2128-30. PubMed ID: 1759836
[TBL] [Abstract][Full Text] [Related]
14. Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitis V; Petraitiene R; Groll AH; Roussillon K; Hemmings M; Lyman CA; Sein T; Bacher J; Bekersky I; Walsh TJ
Antimicrob Agents Chemother; 2002 Jun; 46(6):1857-69. PubMed ID: 12019101
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits.
Petraitiene R; Petraitis V; Groll AH; Candelario M; Sein T; Bell A; Lyman CA; McMillian CL; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 1999 Sep; 43(9):2148-55. PubMed ID: 10471556
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
Van t Wout JW; Mattie H; van Furth R
Antimicrob Agents Chemother; 1989 Feb; 33(2):147-51. PubMed ID: 2541654
[TBL] [Abstract][Full Text] [Related]
17. Hamycin treatment of candidiasis in normal and diabetic rats.
Dhuley JN
FEMS Immunol Med Microbiol; 1999 Nov; 26(2):175-80. PubMed ID: 10536305
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis.
Denning DW; Stevens DA
Antimicrob Agents Chemother; 1991 Jul; 35(7):1329-33. PubMed ID: 1929289
[TBL] [Abstract][Full Text] [Related]
19. Combined antifungal therapy in a murine infection by Candida glabrata.
Mariné M; Serena C; Pastor FJ; Guarro J
J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
